Torrent Pharmaceuticals Limited (BOM:500420)

Triumph Group Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 11, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	1,227,931	1,094,736	880,347	520,309	473,197	430,029
Market Cap Growth	22.22%	24.35%	69.20%	9.96%	10.04%	28.90%
Enterprise Value	1,253,547	1,113,646	917,337	553,029	510,577	476,479
Last Close Price	3628.15	3228.47	2570.72	1500.31	1341.02	1201.04
PE Ratio	61.34	57.28	53.15	41.78	60.89	34.35
Forward PE	46.20	43.21	43.79	35.81	31.03	34.20
PS Ratio	10.38	9.51	8.21	5.41	5.56	5.37
PB Ratio	16.18	14.42	12.84	8.40	7.95	7.37
P/TBV Ratio	41.09	36.63	45.49	67.48	22.04	28.47
P/FCF Ratio	-	55.48	31.07	29.00	29.57	25.75
P/OCF Ratio	-	42.35	26.95	21.97	26.25	21.44
PEG Ratio	2.23	1.90	1.82	1.94	2.34	2.11
EV/Sales Ratio	10.59	9.67	8.55	5.75	6.00	5.95
EV/EBITDA Ratio	32.79	30.30	27.59	19.73	21.43	19.62
EV/EBIT Ratio	41.10	38.06	35.66	25.84	28.86	26.14
EV/FCF Ratio	-	56.44	32.38	30.82	31.90	28.53
Debt / Equity Ratio	0.43	0.43	0.59	0.87	0.69	0.84
Debt / EBITDA Ratio	0.85	0.88	1.21	1.92	1.70	2.00
Debt / FCF Ratio	-	1.65	1.43	3.02	2.57	2.95
Asset Turnover	-	0.77	0.71	0.68	0.63	0.57
Inventory Turnover	-	1.15	1.19	1.17	0.95	0.89
Quick Ratio	-	0.62	0.59	0.54	0.56	0.54
Current Ratio	-	1.19	1.03	0.98	1.20	1.13
Return on Equity (ROE)	-	26.46%	25.38%	20.50%	13.18%	23.49%
Return on Assets (ROA)	-	12.17%	10.69%	9.52%	8.14%	8.11%
Return on Capital (ROIC)	17.54%	16.83%	14.29%	12.34%	10.62%	10.63%
Return on Capital Employed (ROCE)	-	28.50%	26.70%	22.40%	20.40%	19.80%
Earnings Yield	1.63%	1.75%	1.88%	2.39%	1.64%	2.91%
FCF Yield	-	1.80%	3.22%	3.45%	3.38%	3.88%
Dividend Yield	0.89%	0.99%	1.09%	1.47%	1.23%	1.46%
Payout Ratio	-	56.67%	61.30%	41.21%	87.10%	27.03%
Total Shareholder Return	0.88%	0.99%	1.09%	1.47%	1.23%	1.46%

Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.